To confirm whether ERBB proteins are important in controlling RAS/MAPK and PI3K/AKT signalling pathways, we conducted siRNA-mediated knockdown of EGFR and ERBB3 in EML4-ALK+positive NSCLC cell lines. Here, EML4 is linked to non-small cell lung carcinoma.